Publications

5674 Results

Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11).

Authors
A Ajani;KA Winter;LL Gunderson;J Pedersen;A Benson;CR Thomas;RJ Mayer;MG Haddock;TA Rich;CG Willett
Journal / Conference
Cancer Sep 1;116(17):4007-4013
Year
2010
Research Committee(s)
Gastrointestinal
PMID
PMID20564111
PMC
PMC3831519
Study Number(s)
R9811

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node positive breast cancer: a phase 3 open-label, randomised controlled trial [PMID20004966; PMC3140679]

Authors
KS Albain;SJ Green;PM Ravdin;WB Farrar;GV Burton;SJ Ketchel;CD Cobau;EG Levine;JN Ingle;KI Pritchard;AS Lichter;DJ Schneider;MD Abeloff;IC Henderson;L Norton;D Lew;WE Barlow;RB Livingston;S Martino;CK Osborne
Journal / Conference
Lancet 374(9707):2055-2063
Year
2009
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

Failure to achieve a complete response to induction BCG therapy is associated with increased risk of progression and death in patients with high risk non-muscle invasive bladder cancer [PMC2695968; PMID18367117]

Authors
SP Lerner;CM Tangen;H Sucharew;DP Wood;ED Crawford
Journal / Conference
Urologic Oncology 27(2):155-159
Year
2009
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8507

Very late antigen-4 (VLA-4) function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia [PMC2630271; PMID18927435]

Authors
PS Becker;KJ Kopecky;AN Wilks;JM Harlan;CL Willman;SH Petersdorf;T Papayannopoulou;FR Appelbaum
Journal / Conference
Blood 113(4):866-874
Year
2009
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500

Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Onclogy Group study (S0339) [PMID19096312; PMC3024911]

Authors
AM Davies;K Chansky;PN Lara;PH Gumerlock;JJ Crowley;KS Albain;SJ Vogel;DR Gandara
Journal / Conference
Journal of Thoracic Oncology, 4(1):87-92
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0339

A phase II trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx: report of the Southwest Oncology Group [PMID19770418; PMC3098124]

Authors
G Yoo;J Moon;M LeBlanc;F Lonardo;S Urba;H Kim;E Hanna;T Tsue;J Valentino;J Ensley;G Wolf
Journal / Conference
Archives of Otolaryngology Head and Neck Surgery 135(9):869-874
Year
2009
Research Committee(s)
Head and Neck
Study Number(s)
S0011

Phase II evaluation of neoadjuvant chemotherapy and interval debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group study S0009 [PMID19138791]

Authors
AD Tiersten;PY Liu;HO Smith;SP Wilczynski;WR Robinson;M Markman;DS Alberts
Journal / Conference
Gynecologic Oncology 112(3):444-449
Year
2009
Research Committee(s)
Gynecologic
Study Number(s)
S0009

Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336) [PMID18941712; PMC3024913]

Authors
RP Whitehead;C Rankin;PMG Hoff;PJ Gold;KG Billingsley;RA Chapman;L Wong;JL Abruzzese;CD Blanke
Journal / Conference
Investigational New Drugs 27(5):469-475
Year
2009
Research Committee(s)
Gastrointestinal
Study Number(s)
S0336

Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation thalidomide-prednisone maintenance for untreated multiple myeloma: a Southwest Oncology Group Trial (S0204) [PMID19546405; PMC2717757]

Authors
MA Hussein;V Bolejack;JA Zonder;BGM Durie;AJ Jakubowiak;JJ Crowley;B Barlogie
Journal / Conference
Journal of Clinical Oncology 27(21):3510-3517
Year
2009
Research Committee(s)
Myeloma
Study Number(s)
S0204

Long term survival in Waldenstrom macroglobulinemia - 10 year follow-up of Southwest Oncology Group (SWOG) directed intergroup trial S9003 [PMID18931340; PMC2630265]

Authors
MV Dhodapkar;A Hoering;MA Gertz;SE Rivkin;Jackie Szymonifka;J Crowley;Bart Barlogie
Journal / Conference
Blood 113(4)793-796
Year
2009
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9003